Mobile

A Double-Blind, Placebo-Controlled, Randomized, Single-Dose, 2-Period Crossover Study of the Pharmacodynamics of Orally Administered PSI-697 in Healthy Subjects Who Smoke

Update Il y a 4 ans
Reference: EUCTR2007-005695-14

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To assess the pharmacodynamics (PD) of a single oral dose of PSI-697 in healthy subjects who smoke.

Inclusion criteria

  • PSI-697 is an orally active inhibitor of the cellular adhesion molecule P-selectin that offers a unique, first in class mechanism for preventing the vascular atherothrombotic state that is driven by the accumulation leukocytes and platelets in the vascular wall

Links